SEI Investments’s Bicycle Therapeutics BCYC Stock Holding History

SEI Investments’s Portfolio BCYC Stock Details BCYC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$245K	Buy	52,784 +3,728	+8%	+$21.3K	﹤0.01%	2893
2025 Q4	$347K	Hold	49,056	–	–	﹤0.01%	2671
2025 Q3	$380K	Buy	49,056 +38,419	+361%	+$290K	﹤0.01%	2361
2025 Q2	$73.9K	Hold	10,637	–	–	﹤0.01%	2721
2025 Q1	$90.3K	Buy	+10,637	New	+$125K	﹤0.01%	2617
2022 Q1	–	Sell	-3,760	Closed	-$229K	–	2581
2021 Q4	$229K	Buy	+3,760	New	+$207K	﹤0.01%	2429

Other funds holding BCYC

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

GSK plc London $599M AUM

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SEI Investments's BCYC Position: Q1 2026 in Review

SEI Investments increased its Bicycle Therapeutics (BCYC) stake by 7.6% in Q1 2026, buying an estimated $21.3K and bringing the position to 52,784 shares worth $245K. The position accounts for ﹤0.01% of the portfolio, ranked #2893.

SEI Investments first reported a position in BCYC in Q4 2021 and has held it in 6 quarters since. The position peaked at $380K in Q3 2025. 98 funds tracked by Wall St. Rank hold BCYC as of Q1 2026.

SEI Investments held 52,784 shares of Bicycle Therapeutics worth $245K as of Q1 2026.
SEI Investments bought 3,728 Bicycle Therapeutics shares in Q1 2026, an estimated $21.3K.
Bicycle Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q1 2026, its #2893 holding.
SEI Investments first reported a position in Bicycle Therapeutics in Q4 2021 and has held it in 6 quarters since.
SEI Investments's Bicycle Therapeutics position peaked at $380K in Q3 2025.
98 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.